STOCK TITAN

10X Genomics, Inc. SEC Filings

TXG NASDAQ

Welcome to our dedicated page for 10X Genomics SEC filings (Ticker: TXG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission (SEC) filings for 10x Genomics, Inc. (NASDAQ: TXG), a life science technology company specializing in single cell and spatial biology. Through these filings, investors and researchers can review the company’s regulatory disclosures, including annual and quarterly reports and current reports on material events.

10x Genomics’ Class A common stock is registered on The Nasdaq Stock Market LLC under the symbol TXG, as noted in its Form 8-K filings. The company uses SEC filings, along with its website, press releases, public conference calls, webcasts and social media accounts, as channels for disclosing information and for complying with Regulation FD. Form 8-K filings have addressed topics such as quarterly financial results and changes in certain executive roles.

Key SEC documents for TXG include annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain detailed information about revenue by product type and geography, gross margin, operating expenses, cash and marketable securities, and risk factors. Current reports on Form 8-K provide timely updates on specific events, such as earnings releases or leadership changes. Together, these filings give a structured view of how 10x Genomics’ single cell and spatial biology business is performing and evolving.

On Stock Titan, users can view TXG filings as they are made available from EDGAR and use AI-powered summaries to interpret complex sections, such as revenue breakdowns, operating results and risk disclosures. Filings related to topics like license and royalty revenue, services, and geographic revenue distribution can be examined to understand the company’s financial profile. This page also offers convenient access to insider and governance-related filings, helping users track corporate developments over time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of 10X Genomics (TXG)?

The current stock price of 10X Genomics (TXG) is $19.66 as of February 25, 2026.

What is the market cap of 10X Genomics (TXG)?

The market cap of 10X Genomics (TXG) is approximately 2.4B.

TXG Rankings

TXG Stock Data

2.44B
115.51M
Health Information Services
Laboratory Analytical Instruments
Link
United States
PLEASANTON

TXG RSS Feed